On the HCC Treatment Horizon

On the HCC Treatment Horizon

Episodes

Specialty:

All

Year:

All

EP. 1: Hepatocellular Carcinoma: A Changing Treatment Landscape

February 8th 2018

EP. 2: REFLECT Trial: Frontline Lenvatinib's Value in HCC

February 8th 2018

EP. 3: CELESTIAL Trial: Second-Line Cabozantinib's Value in HCC

February 8th 2018

EP. 4: Immunotherapy Approaches in Hepatocellular Carcinoma

February 8th 2018

EP. 5: KEYNOTE-224: Second-Line Pembrolizumab

February 8th 2018

EP. 6: Locoregional Approaches in Hepatocellular Carcinoma

February 8th 2018

EP. 7: The Future of Treatment in Hepatocellular Carcinoma

February 8th 2018

Trending on OncLive

INBRX-106 Plus Pembrolizumab Improves Responses and PFS in First-Line PD-L1–Positive HNSCC

FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL

The OncFive: Top Oncology Articles for the Week of 9/27/2026

NDA Submission Is Initiated for Zipalertinib Plus Chemotherapy in Frontline EGFR Exon 20 Insertion+ NSCLC

Five Under 5: Top Oncology Videos for the Week of 9/27